Fidelity Investments’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.21B | Buy |
3,131,652
+1,155,933
| +59% | +$429M | 0.05% | 271 |
|
|
2026
Q1 | $578M | Buy |
1,975,719
+496,448
| +34% | +$163M | 0.03% | 462 |
|
|
2025
Q4 | $519M | Buy |
1,479,271
+103,856
| +8% | +$35.1M | 0.03% | 492 |
|
|
2025
Q3 | $444M | Buy |
1,375,415
+92,235
| +7% | +$28.7M | 0.02% | 549 |
|
|
2025
Q2 | $499M | Sell |
1,283,180
-261,407
| -17% | -$105M | 0.03% | 486 |
|
|
2025
Q1 | $672M | Sell |
1,544,587
-648,144
| -30% | -$260M | 0.04% | 352 |
|
|
2024
Q4 | $809M | Sell |
2,192,731
-2,426,019
| -53% | -$1.02B | 0.05% | 312 |
|
|
2024
Q3 | $2.4B | Sell |
4,618,750
-128,083
| -3% | -$68.4M | 0.15% | 113 |
|
|
2024
Q2 | $2.57B | Buy |
4,746,833
+693,525
| +17% | +$367M | 0.16% | 88 |
|
|
2024
Q1 | $2.1B | Buy |
4,053,308
+87,322
| +2% | +$43.4M | 0.14% | 115 |
|
|
2023
Q4 | $1.87B | Sell |
3,965,986
-249,992
| -6% | -$116M | 0.14% | 113 |
|
|
2023
Q3 | $1.84B | Sell |
4,215,978
-191,531
| -4% | -$86.9M | 0.16% | 103 |
|
|
2023
Q2 | $1.96B | Sell |
4,407,509
-401,586
| -8% | -$185M | 0.16% | 101 |
|
|
2023
Q1 | $2.21B | Sell |
4,809,095
-1,445,007
| -23% | -$688M | 0.2% | 86 |
|
|
2022
Q4 | $3.21B | Sell |
6,254,102
-269,117
| -4% | -$137M | 0.32% | 55 |
|
|
2022
Q3 | $2.96B | Sell |
6,523,219
-24,762
| -0.4% | -$11.8M | 0.31% | 52 |
|
|
2022
Q2 | $3.16B | Sell |
6,547,981
-331,047
| -5% | -$164M | 0.31% | 48 |
|
|
2022
Q1 | $3.38B | Buy |
6,879,028
+390,533
| +6% | +$179M | 0.27% | 53 |
|
|
2021
Q4 | $3.01B | Buy |
6,488,495
+102,963
| +2% | +$43.3M | 0.22% | 65 |
|
|
2021
Q3 | $2.38B | Sell |
6,385,532
-565,858
| -8% | -$215M | 0.19% | 88 |
|
|
2021
Q2 | $2.65B | Buy |
6,951,390
+74,543
| +1% | +$28.5M | 0.21% | 79 |
|
|
2021
Q1 | $2.47B | Sell |
6,876,847
-1,856,190
| -21% | -$597M | 0.21% | 81 |
|
|
2020
Q4 | $2.8B | Buy |
8,733,037
+244,712
| +3% | +$75.1M | 0.25% | 64 |
|
|
2020
Q3 | $2.28B | Buy |
8,488,325
+508,915
| +6% | +$137M | 0.23% | 76 |
|
|
2020
Q2 | $2.1B | Buy |
7,979,410
+477,208
| +6% | +$127M | 0.23% | 73 |
|
|
2020
Q1 | $1.7B | Buy |
7,502,202
+13,673
| +0.2% | +$3.73M | 0.24% | 82 |
|
|
2019
Q4 | $2.26B | Sell |
7,488,529
-375,308
| -5% | -$103M | 0.25% | 70 |
|
|
2019
Q3 | $1.89B | Sell |
7,863,837
-1,651,914
| -17% | -$453M | 0.23% | 81 |
|
|
2019
Q2 | $2.69B | Sell |
9,515,751
-923,648
| -9% | -$252M | 0.31% | 56 |
|
|
2019
Q1 | $3B | Sell |
10,439,399
-904,336
| -8% | -$262M | 0.36% | 44 |
|
|
2018
Q4 | $2.98B | Buy |
11,343,735
+712,371
| +7% | +$196M | 0.41% | 38 |
|
|
2018
Q3 | $2.91B | Buy |
10,631,364
+725,224
| +7% | +$188M | 0.33% | 46 |
|
|
2018
Q2 | $2.36B | Buy |
9,906,140
+731,074
| +8% | +$169M | 0.27% | 57 |
|
|
2018
Q1 | $2.02B | Sell |
9,175,066
-213,290
| -2% | -$50.1M | 0.24% | 74 |
|
|
2017
Q4 | $2.11B | Sell |
9,388,356
-559,618
| -6% | -$119M | 0.25% | 72 |
|
|
2017
Q3 | $1.89B | Sell |
9,947,974
-105,822
| -1% | -$20.1M | 0.23% | 78 |
|
|
2017
Q2 | $1.89B | Sell |
10,053,796
-2,281,319
| -18% | -$410M | 0.24% | 76 |
|
|
2017
Q1 | $2.04B | Buy |
12,335,115
+934,509
| +8% | +$149M | 0.26% | 71 |
|
|
2016
Q4 | $1.64B | Buy |
11,400,606
+1,097,145
| +11% | +$147M | 0.22% | 87 |
|
|
2016
Q3 | $1.29B | Buy |
10,303,461
+1,269,859
| +14% | +$164M | 0.17% | 116 |
|
|
2016
Q2 | $1.19B | Buy |
9,033,602
+770,894
| +9% | +$105M | 0.16% | 133 |
|
|
2016
Q1 | $1.15B | Buy |
8,262,708
+599,579
| +8% | +$80.1M | 0.16% | 132 |
|
|
2015
Q4 | $1.07B | Sell |
7,663,129
-1,459,828
| -16% | -$201M | 0.14% | 144 |
|
|
2015
Q3 | $1.28B | Sell |
9,122,957
-1,511,558
| -14% | -$227M | 0.18% | 117 |
|
|
2015
Q2 | $1.75B | Sell |
10,634,515
-368,349
| -3% | -$58.9M | 0.22% | 88 |
|
|
2015
Q1 | $1.7B | Buy |
11,002,864
+8,593
| +0.1% | +$1.22M | 0.22% | 90 |
|
|
2014
Q4 | $1.38B | Buy |
10,994,271
+146,298
| +1% | +$18.1M | 0.18% | 118 |
|
|
2014
Q3 | $1.3B | Buy |
10,847,973
+1,009,530
| +10% | +$116M | 0.18% | 121 |
|
|
2014
Q2 | $1.06B | Buy |
9,838,443
+1,324,873
| +16% | +$137M | 0.14% | 149 |
|
|
2014
Q1 | $848M | Sell |
8,513,570
-1,694,608
| -17% | -$153M | 0.12% | 181 |
|
|
2013
Q4 | $943M | Sell |
10,208,178
-288,149
| -3% | -$25.6M | 0.13% | 168 |
|
|
2013
Q3 | $878M | Sell |
10,496,327
-3,179,213
| -23% | -$272M | 0.13% | 168 |
|
|
2013
Q2 | $1.12B | Buy |
+13,675,540
| New | +$1.02B | 0.18% | 114 |
|
Other funds holding ELV
Fidelity Investments's ELV Position: Q2 2026 in Review
Fidelity Investments increased its Elevance Health (ELV) stake by 59% in Q2 2026, buying an estimated $429M and bringing the position to 3,131,652 shares worth $1.21B. The position accounts for 0.05% of the portfolio, ranked #271.
Fidelity Investments first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.38B in Q1 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Fidelity Investments held 3,131,652 shares of Elevance Health worth $1.21B as of Q2 2026.
- Fidelity Investments bought 1,155,933 Elevance Health shares in Q2 2026, an estimated $429M.
- Elevance Health made up 0.05% of Fidelity Investments's portfolio in Q2 2026, its #271 holding.
- Fidelity Investments first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- Fidelity Investments's Elevance Health position peaked at $3.38B in Q1 2022.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.